• PDF: Delivered by email usually within 48 UK business hours.

Orient Europharma Co., Ltd. (4120) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Publication Date:January 2013
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:25

Orient Europharma Co., Ltd. (4120) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Orient Europharma Co., Ltd. (Orient Europharma) is a pharmaceutical company, based in Taiwan. It researches, develops, manufactures, markets and sells pharmaceuticals and health care products. The company offers products in the fields of general pharmaceutical, oncology, dermo-cosmetics, nutrition and baby care and healthcare supplement. Orient products include Zanidip F.C., Diltelan capsules, Verelan sustained release capsules, Mycros tablets, Carginine, anti-cancer drug, anti-hemophilia drug, ADerma, DUCRAY, NOV, KIBIO, Cumlaude, Karihome, Babecare, Ostricare, Supercare, Infacare, Karimed, Vitaglow and Buccotherm. It partners with UCB, Medinox, Besins, Pfizer, Q-Med, NOV, Almirall and HRA Pharma. The company operates through subsidiaries in China, Hong Kong, Vietnam, Malaysia, Singapore and the Philippines. Orient Europharma is headquartered in Taipei, Taiwan.

Orient Europharma Co., Ltd. (4120) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals and Healthcare eTrack deals database, and primary and secondary research.

Scope

  • Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

  • Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.

  • Contents
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deal Details
    • Partnerships
    • UCB Enters Into Co-Marketing Agreement With Orient Europharma
    • AndroScience Enters Into Collaboration With Orient Europharma
    • Medinox Enters Into Co-Development Agreement With Orient Europharma
    • Orient Europharma Forms Joint Venture With C5Rx Pharma
    • HRA Pharma Enters Into An Agreement With Orient Europharma
    • Orient Europharma Enters Into Co-Marketing Agreement With Senju Pharma
    • Orient Europharma Enters Into Co-Marketing Agreement With Chiesi Farmaceutici
    • PharmaNova Enters Into Co-Development Agreement With Orient Europharma
    • Licensing Agreements
    • Orient Europharma Enters Into Licensing Agreement With Handok Pharma
    • CEL-SCI Enters Into Licensing Agreement With Orient Europharma
    • Orient Europharma Enters Into Licensing Agreement with NanoCarrier
    • Orient Europharma Co., Ltd. - Key Competitors
    • Key Employees
    • Locations And Subsidiaries
    • Head Office
    • Appendix
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
  • List of Tables
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Key Facts, 2011
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Deals By Therapy Area, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013
    • UCB Enters Into Co-Marketing Agreement With Orient Europharma
    • AndroScience Enters Into Collaboration With Orient Europharma
    • Medinox Enters Into Co-Development Agreement With Orient Europharma
    • Orient Europharma Forms Joint Venture With C5Rx Pharma
    • HRA Pharma Enters Into An Agreement With Orient Europharma
    • Orient Europharma Enters Into Co-Marketing Agreement With Senju Pharma
    • Orient Europharma Enters Into Co-Marketing Agreement With Chiesi Farmaceutici
    • PharmaNova Enters Into Co-Development Agreement With Orient Europharma
    • Orient Europharma Enters Into Licensing Agreement With Handok Pharma
    • CEL-SCI Enters Into Licensing Agreement With Orient Europharma
    • Orient Europharma Enters Into Licensing Agreement with NanoCarrier
    • Orient Europharma Co., Ltd., Key Competitors
    • Orient Europharma Co., Ltd., Key Employees
  • List of Figures
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013
    • Orient Europharma Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013
+44 20 8816 8548

Ask a question about Orient Europharma Co., Ltd. (4120) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Enter the characters you see in the picture below
Captcha